Zevra to Present Data from KP1077 Phase 2 Trial in IH at SLEEP
Zevra's CEO updates shareholders on recent milestones, including the completion of a phase 2 trial for idiopathic hypersomnia.
Source: sleepreviewmag.com
Neil Mcfarlane News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Neil Mcfarlane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Neil Mcfarlane Today - Breaking & Trending Today
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2.
Source: insidermonkey.com
Zevra Reports Positive Phase 2 Results for IH Drug Candidate
Zevra Therapeutics announced positive topline results from its phase 2 clinical trial evaluating KP1077 for idiopathic hypersomnia (IH).
Source: sleepreviewmag.com
Zevra Therapeutics Announces Top-Line Data from the Phase 2
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study ...
Source: globenewswire.com
Former PMs' visit to Israel is a weak publicity stunt
For Scott Morrison and Boris Johnson, to visit one scene of inhumanity and show support for the Israeli actions while ignoring Ukraine smacks of a desperate attempt for relevance
Source: smh.com.au